REVEFENACIN - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2023-08-29
- Label type
- Indexing - product concept
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 00:21:57
Label at a glance#
ProductREVEFENACIN
Active ingredientREVEFENACIN
Products#
Every source-derived product name is available through these pages.
- REVEFENACIN
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| REVEFENACIN | G2AE2VE07O | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| YUPELRI | REVEFENACIN | Viatris Specialty LLC | 6dfebf04-7c90-436a-9b16-750d3c1ee0a6 | 2022-05-03 | Warnings, Adverse reactions | REVEFENACIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.